Nymox (+8%) on track to file fexapotide applications in ~four months
Seeking Alpha - Article · 06/19 15:54
Nymox Announces Updates in Regulatory Submissions For Fexapotide Treatment For Prostate Enlargement
GlobeNewswire · 06/19 14:30
Nymox Pharma Offers Update On Regulatory Submissions For Fexapotide Treatment For Prostate Enlargement
Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is very pleased to report that key steps in its regulatory submission preparations have been completed and the project is firmly on-track. The majority of its regulatory
Benzinga · 06/19 13:31
The Daily Biotech Pulse: GlaxoSmithKline, IDEAYA Strike Oncology Partnership, Decision Day For Merck, Adverum's New CEO
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 16)